In-Vivo Disease Modeling Unit


The In Vivo Disease Modeling Unit employs state-of-art, validated rodent models of cardiac, pulmonary, renal, and hepatic fibrosis to discover novel pathogenic mechanisms and to assess the efficacy of interventional therapeutics. 

Organ fibrosis in these models is triggered by genetic, surgical and/or chemical manipulation, and the high quality data that are produced enable critical go/no-go decisions about projects and therapeutic strategies.    


systolic heart failure

Contact Maria Cavasin today for your free consultation and setting up your study



CMS Login